Cyted Health logo — Transforming access to digestive health for everyone, everyw...

Cyted Health

Transforming access to digestive health for everyone, everywhere.

Founded 2020 United Kingdom Cambridge, United Kingdom 74 employees Non Equity Assistance Total: $33.22M AI, Biotechnology +2

General Information

Company Name Cyted Health
Founded Year 2020
Location United Kingdom Cambridge, United Kingdom +1
Founders / Decision Makers
Team member
Employees 74
Industries AI, Biotechnology, Health Care +1
Funding Stage Non Equity Assistance
Social

Get notified when Cyted Health moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Homepage Update

Significant changes detected on company website (34.5% content change).

Event Participation Aug 25, 2026

Data highlighting the growing role of capsule sponge technology and EndoSign® in Barrett’s esophagus surveillance was presented at #DDW2026.

Actively Hiring Aug 22, 2026

Hiring for 2 positions in the last 30 days.

New Partnership Aug 13, 2026

Cyted Health's EndoSign® capsule sponge testing is now offered through selected Boots UK and community pharmacies, as part of the COMPASS project.

Major Customer Win Aug 13, 2026

Cyted Health's EndoSign® product is already in routine clinical use within NHS hospitals, signifying significant customer adoption.

Growth Metrics Aug 10, 2026

As part of Project COMPASS, 25 patients who used Cyted Health's test were subsequently sent for further medical investigation.

AI Insight

Bounce Watch AI
6 days ago

Cyted Health is demonstrating robust commercial traction with its non-endoscopic diagnostic platform, EndoSign®. The company has successfully secured routine clinical use within NHS hospitals and established a key distribution partnership with Boots UK and community pharmacies, significantly expanding patient access. These developments highlight a strategic shift towards widespread adoption and a strong impact on early cancer detection, further supported by positive patient outcomes and scientific validation.

Signal Types
Traction Partnership Customer Adoption Market Expansion Product Update
Strategic Labels
Market Penetration Clinical Adoption Healthcare Access
Next Move: Fundraising
·
Impact: 9/10
·
Ideal For: Growth-stage HealthTech VCs

About Cyted Health

Cyted Health is a promising startup founded in 2020, headquartered in the United Kingdom, and focused on revolutionizing the field of digestive health. With the slogan "Transforming access to digestive health for everyone, everywhere," the company is making strides in AI, Biotechnology, Health Care, and Medical Devices by developing non-endoscopic diagnostic tools.

The innovative approach taken by Cyted Health involves early disease detection, improving accessibility to care, and ultimately enhancing patient outcomes. This goal aligns with the broader industry trend of leveraging technology to democratize healthcare access.

In terms of financial backing, the company recently attracted a Non Equity Assistance investment on 29 May 2024, with support from the reputable MedTech Innovator. This partnership not only highlights confidence in Cyted Health's mission but also provides valuable resources for its continued growth and technological development.

Taxonomy: Digestive Health, Non-Endoscopic Diagnostics, Early Disease Detection, Digital Diagnostic Infrastructure, Novel Biomarkers, Clinical Insight, Patient Outcomes, Disease Prevention, Healthcare Innovation, Diagnostic Revolution, Medical Technology, Health Accessibility, Predictive Healthcare, Diagnostic Methods

Services & Products

EndoSign® Capsule Sponge Device
High-resolution Molecular Analysis
Diagnostic Testing

Target Customers

Clinicians Patients with Esophageal Disease Pharmacies Healthcare Providers

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance •••••• 1
Investor
29 May 2024
Grant •••••• 1
Investor
12 Dec 2023
Series A •••••• 2
Investor Investor
17 May 2023
Grant •••••• 1 •••• •••• 01 Apr 2023
Grant •••••• 1
Investor
14 Apr 2022

View All 9 Funding Rounds

Cyted Health Alternatives & Competitors

View All Alternatives
Cyted Health vs

Focused on Reducing Cancer Incidence Around the World

Seed
8 employees
Health Care
Cyted Health vs

Next Generation Multimodal Screening Modality

Grant
5 employees
Health Care, Medical Devices
Cyted Health vs
EnLiSense LLC
EnLiSense LLC United States

EnLiSense biosensors and platform technologies enables tracking of WELLNESS to ILLNESS and back to W...

Grant
7 employees
Health Care, Manufacturing

FAQ About Cyted Health

Transforming access to digestive health for everyone, everywhere.
Cyted Health was founded in 2020.
Cyted Health is headquartered in Cambridge, United Kingdom.
Cyted Health operates in the following industries: AI, Biotechnology, Health Care, Medical Devices.
Cyted Health has approximately 74 employees.
Cyted Health has completed 9 funding rounds, raising a total of $33.22M. The latest funding stage is Non Equity Assistance.
Cyted Health offers: EndoSign® Capsule Sponge Device, High-resolution Molecular Analysis, Diagnostic Testing.
Top alternatives and competitors to Cyted Health include Proteocyte AI, ThermoMind, EnLiSense LLC, MagBioSense, Improdia. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cyted Health and Proteocyte AI are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cyted Health and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy